[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-caris-life-sciences-stocks-gross-margin-story-from-38-to-65-in-seven-quarters-and-what-comes-next-EN":150},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[],{"post":151,"seo":187,"relatedPosts":194,"suggestedPosts":270},{"id":152,"title":153,"date":154,"modified":155,"excerpt":156,"content":157,"wordCount":158,"lang":159,"uri":160,"slug":161,"cloudinaryAssetId":162,"featuredImageOriginalUrl":163,"featuredImageMetadata":164,"author":167,"editor":173,"categories":178,"relatedPosts":184,"seo":185},110732,"Caris Life Sciences Stock’s Gross Margin Story: From 38% to 65% in Seven Quarters and What Comes Next","2026-06-12T12:30:00","2026-06-12T05:42:37","\u003Cp>Caris Life Sciences stock’s gross margins expanded from 38% to 65% in seven quarters. The operating cost structure barely moved.\u003C\u002Fp>\n","\n\u003Ch2 class=\"wp-block-heading\" id=\"h-key-takeaways-for-caris-life-sciences-stock\">\u003Cstrong>Key Takeaways for Caris Life Sciences Stock\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Total revenue grew 79% year-over-year to $216.2 million in Q1 2026, with molecular profiling services leading at 85% growth to $211 million.\u003C\u002Fli>\n\n\n\n\u003Cli>Gross margins expanded from 47% in Q1 2025 to 65% in Q1 2026, an improvement of 18 percentage points in four quarters.\u003C\u002Fli>\n\n\n\n\u003Cli>TIKR’s mid-case model values Caris Life Sciences stock at approximately $159 by December 2030, implying around 560% total return from the current price of $18.\u003C\u002Fli>\n\n\n\n\u003Cli>Caris Detect delivered 60% Stage I and Stage II sensitivity with 99% asymptomatic specificity across 3,014 subjects in the Achieve 1 study.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>The income statement shows 79% revenue growth with gross margins already at 65%, but the stock is trading near its 52-week low. \u003Ca href=\"https:\u002F\u002Ftikr.com\u002F\">Pull up Caris Life Sciences stock financial data on TIKR for free →\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-caris-life-sciences-stock-turns-profitable-on-asp-surge-as-detect-launch-approaches\">Caris Life Sciences Stock Turns Profitable on ASP Surge as Detect Launch Approaches\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"466\" data-public-id=\"images\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_466,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA\" alt=\"caris life sciences stock q1 2026 earnings\" class=\"wp-post-110732 wp-image-110734\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1781242157\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_466,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_137,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_349,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_546,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_637,c_scale\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1781242157\u002Fimages\u002Fimage-444_1107348f0a8\u002Fimage-444_1107348f0a8.png?_i=AA 1446w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">CAI Stock Q1 2026 Earnings in USD \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ftranscript?cid=285971879&tid=1675451254&e=1996097437&ts=3717986&ref=q2enxr\">(TIKR)\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Caris Life Sciences (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=285971879&tid=1675451254&ref=q2enxr\">CAI\u003C\u002Fa>) reported Q1 2026 revenue of $216.2 million, up 79% year-over-year, following a sales force realignment that disrupted January but drove record activations in February and March.\u003C\u002Fp>\n\n\n\n\u003Cp>The company provides comprehensive molecular profiling for cancer patients, using whole exome and transcriptome sequencing across 23,000 genes to identify therapy options, clinical trial eligibility, and resistance markers. Every profiled patient feeds a proprietary dataset now exceeding 1 million cases, which powers both clinical AI tools and biopharma partnerships.\u003C\u002Fp>\n\n\n\n\u003Cp>Molecular profiling services, which accounted for $211 million of Q1 revenue, grew 85% year-over-year on two engines running simultaneously: a 15% increase in clinical case volume to 52,800 cases, and a 61% increase in average selling price (ASP) for comprehensive profiling tests.\u003C\u002Fp>\n\n\n\n\u003Cp>CFO Luke Power attributed the ASP expansion directly to MI Cancer Seek, the company’s FDA-approved whole exome and transcriptome tissue assay: tissue ASP increased 70% to over $4,300 and blood ASP increased 14% to just under $2,500, driven by payer contracting wins and over 225 million covered lives now secured for MI Cancer Seek.\u003C\u002Fp>\n\n\n\n\u003Cp>CCO Bobby Hill stated on the \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ftranscript?cid=285971879&tid=1675451254&e=1996097437&ts=3717986&ref=q2enxr\">Q1 earnings call\u003C\u002Fa>: “Activations in February and March grew approximately 20% year-over-year compared with the same 2 months period last year.”\u003C\u002Fp>\n\n\n\n\u003Cp>The exit run rate from February and March implied approximately 56,000 completed cases per quarter, supporting management’s guidance for over 58,000 cases in Q2, a 10% sequential increase from Q1.\u003C\u002Fp>\n\n\n\n\u003Cp>Two new products launched in Q2: Caris ChromoSeq, a whole-genome therapy selection assay for hematological cancers priced at $3,228, which received MolDX approval; and Caris MI Clarity, a digital pathology AI test for breast cancer recurrence risk. Neither is included in the current full-year guidance of $1.0 billion to $1.02 billion in revenue.\u003C\u002Fp>\n\n\n\n\u003Cp id=\"h-what-happened\">The most consequential near-term catalyst remains Caris Detect, the company’s multi-cancer early detection test built on whole genome sequencing. The Achieve 1 study, a 3,014-subject cohort, reported 60% Stage I and Stage II sensitivity with 99% asymptomatic specificity. CSO Milan Radovich described the result as generated using only one of nine potential biological pillars, suggesting significant upside in performance as the platform matures. Commercial launch with Everlywell is planned for Q2 2026.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>The sales realignment disrupted January but February and March proved the demand is real. The volume data, ASP trends, and Detect timeline are all on TIKR. \u003Ca href=\"https:\u002F\u002Ftikr.com\u002F\">See the full financial history of Caris Life Sciences stock on TIKR for free →\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-is-caris-life-sciences-stock-undervalued-the-gross-margin-story-says-yes\">Is Caris Life Sciences Stock Undervalued? The Gross Margin Story Says Yes\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"672\" data-public-id=\"images\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_672,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA\" alt=\"caris life sciences stock quarterly financials\" class=\"wp-post-110732 wp-image-110736\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1781242481\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_672,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_197,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_504,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1007,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_787,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_918,c_scale\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1781242481\u002Fimages\u002Fimage-445_1107367f095\u002Fimage-445_1107367f095.png?_i=AA 1668w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">CAI Stock Quarterly Financials \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ffinancials?cid=285971879&tid=1675451254&tab=is&ref=q2enxr\">(TIKR)\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Caris Life Sciences stock’s gross margin expanded from 38% in Q2 2024 to 65% in Q1 2026, a 27-percentage-point improvement across seven quarters driven almost entirely by ASP catching up to the cost of whole exome and transcriptome sequencing.\u003C\u002Fp>\n\n\n\n\u003Cp>The cost of goods sold remained nearly flat across that same period, holding between $0.06 billion and $0.07 billion per quarter while revenue more than doubled, which is the operating leverage signature of a platform where fixed sequencing infrastructure serves a growing revenue base.\u003C\u002Fp>\n\n\n\n\u003Cp>The gap between gross margin (65%) and operating margin (2%) in Q1 2026 reflects a deliberate reinvestment cycle: SG&A of $0.10 billion and R&D of $0.03 billion consumed nearly all of the gross profit generated during the quarter, as the company expanded its salesforce from 82 to 146 territories and prepared for the Detect launch.\u003C\u002Fp>\n\n\n\n\u003Cp>Gross profit grew 148% year-over-year in Q1 2026 while total operating expenses grew only 18%, a ratio that shows the reinvestment is not outrunning the underlying margin engine.\u003C\u002Fp>\n\n\n\n\u003Cp id=\"h-wall-street-s-take-on-x-stock\">The trough in operating margin came in Q2 2024 at negative 67%, crossed into positive territory in Q3 2025 at 15%, peaked at 30% in Q4 2025, and compressed to 2% in Q1 2026 as the company front-loaded Detect and salesforce investments. That compression is an investment cycle, not a margin reversal.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">CAI Has Closed the Gross Margin Gap on GH and Now Trades at Parity With Both Peers\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"679\" data-public-id=\"images\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_679,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA\" alt=\"caris life sciences stock gross margins vs gh stock and tem stock\" class=\"wp-post-110732 wp-image-110737\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1781242703\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_679,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_199,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_509,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1018,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_795,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_928,c_scale\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 1400w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1781242703\u002Fimages\u002Fimage-446_110737ace26\u002Fimage-446_110737ace26.png?_i=AA 1660w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">CAI Stock Gross Margins vs GH Stock and TEM Stock \u003Cstrong>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ffinancials?cid=285971879&tid=1675451254&tab=is&ref=q2enxr\">(TIKR)\u003C\u002Fa>\u003C\u002Fstrong>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Caris Life Sciences stock’s gross margin sat 22 percentage points below Guardant Health (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ffinancials?cid=285971879&tid=1675451254&tab=is&ref=q2enxr\">GH\u003C\u002Fa>) in Q2 2024, with CAI at 38% and GH at 59%, a gap that reflected CAI’s earlier stage of reimbursement maturity rather than any structural cost disadvantage.\u003C\u002Fp>\n\n\n\n\u003Cp>By Q3 2025, Caris Life Sciences stock had closed that gap entirely, reaching 68% against GH’s 65%, the first quarter in which CAI crossed above its liquid biopsy peer on gross margin, driven by the same ASP expansion engine that pushed tissue pricing up 70% year-over-year.\u003C\u002Fp>\n\n\n\n\u003Cp>Tempus AI (\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Ffinancials?cid=285971879&tid=1675451254&tab=is&ref=q2enxr\">TEM\u003C\u002Fa>) held gross margins in the 60% to 63% range throughout the entire comparison period, providing a stable ceiling that both CAI and GH have now reached, which suggests 65% represents the category norm for scaled molecular diagnostics platforms rather than a Caris-specific ceiling.\u003C\u002Fp>\n\n\n\n\u003Cp>The strategic implication for Caris Life Sciences stock is that the gross margin catch-up trade is largely complete, and the next margin expansion lever sits in operating expense normalization as Detect, ChromoSeq, and MI Clarity convert from investment-stage launches into recurring revenue contributors at the existing 65% gross margin base.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">TIKR’s $159 Mid-Case on CAI Stock: What Has to Hold for the Numbers to Work\u003C\u002Fh2>\n\n\n\n\u003Cp>TIKR’s base case values Caris Life Sciences at approximately $159 by December 2030, implying around 560% total return from the current price of $18, or roughly 51% annualized over 4.5 years.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg width=\"1024\" height=\"832\" data-public-id=\"images\u002FCAI_valuation_model\u002FCAI_valuation_model.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA\" alt=\"caris life sciences stock valuation model results\" class=\"wp-post-110732 wp-image-110735\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1781242224\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_832,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_244,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_624,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1536,h_1248,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 1536w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_2048,h_1663,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 2048w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_975,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_1137,c_scale\u002Ff_webp,q_auto\u002Fv1781242224\u002Fimages\u002FCAI_valuation_model\u002FCAI_valuation_model.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">CAI Stock Valuation Model Results \u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>(TIKR)\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>If revenue growth sustains around the mid-case trajectory of approximately 13% CAGR with net income margins converging toward 18%, the model supports that target. The mechanism is the gross margin base already established at 65%, plus the operating leverage embedded in a fixed sequencing cost structure as revenue compounds from new products including ChromoSeq, MI Clarity, and Detect.\u003C\u002Fp>\n\n\n\n\u003Cp>In the low case, with approximately 12% revenue CAGR and approximately 17% net income margins, the model produces a stock price of around $112 by December 2030, implying around 523% total return, or roughly 24% annualized.\u003C\u002Fp>\n\n\n\n\u003Cp>In the high case, with approximately 15% revenue CAGR and approximately 19% net income margins, the model produces approximately $218, implying around 1,113% total return, or roughly 34% annualized.\u003C\u002Fp>\n\n\n\n\u003Cp>The condition separating the mid from the low case is not revenue volume, which is tracking ahead of guidance, but the pace of operating expense normalization as Detect and new salesforce additions mature into recurring revenue contributions.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Wall Street’s best ideas don’t stay hidden for long. Catch analyst upgrades, earnings beats, and revenue surprises on thousands of stocks the moment they happen with TIKR for free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Is Caris Life Sciences stock a buy right now?\u003C\u002Fh2>\n\n\n\n\u003Cp>Caris Life Sciences stock is trading near its 52-week low of $17 while the underlying business is delivering 79% revenue growth and 65% gross margins. \u003C\u002Fp>\n\n\n\n\u003Cp>TIKR’s mid-case model values the stock at approximately $159 by December 2030, implying around 560% total return from current levels. \u003C\u002Fp>\n\n\n\n\u003Cp>The investment case depends on the company sustaining gross margin discipline while converting Detect and ChromoSeq launches into durable revenue streams.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-should-you-invest-in-caris-life-sciences-inc\">\u003Cstrong>Should You Invest in Caris Life Sciences, Inc.?\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.\u003C\u002Fp>\n\n\n\n\u003Cp>Pull up Caris Life Sciences, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.\u003C\u002Fp>\n\n\n\n\u003Cp>You can build a free watchlist to track Caris Life Sciences, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Access Professional Tools to Analyze CAI stock on TIKR for Free →\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n",1450,"en","\u002Fblog\u002Fcaris-life-sciences-stocks-gross-margin-story-from-38-to-65-in-seven-quarters-and-what-comes-next","caris-life-sciences-stocks-gross-margin-story-from-38-to-65-in-seven-quarters-and-what-comes-next","images\u002FFEATURED-IMAGE-MAKER-839-1\u002FFEATURED-IMAGE-MAKER-839-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781242941\u002Fimages\u002FFEATURED-IMAGE-MAKER-839-1\u002FFEATURED-IMAGE-MAKER-839-1.png?_i=AA",{"altText":165,"imageCredit":166},"Caris Life Sciences Stock’s Gross Margin Story: From 38% to 65% in Seven Quarters and What Comes Next","TIKR",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":172},"Gian Estrada","giantikr","author","",[],{"name":174,"slug":175,"role":176,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":177},"David Hanson","davidtikr","editor",[],[179],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},"Stock Reviews","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":165,"metaDesc":186,"opengraphDescription":186,"twitterTitle":165,"twitterDescription":186},"Caris Life Sciences stock’s gross margins expanded from 38% to 65% in seven quarters. The operating cost structure barely moved.",{"title":153,"description":188,"twitterTitle":153,"twitterDescription":188,"author":168,"articlePublisher":189,"articlePublishedTime":154,"articleModifiedTime":155,"twitterLabel1":190,"twitterData1":191,"ogTitle":153,"ogDescription":188,"ogUrl":160,"ogImage":163,"ogImageWidth":192,"ogImageHeight":193,"ogImageSecureUrl":163,"ogImageAlt":165,"twitterImage":163},"Caris Life Sciences stock’s gross margins expanded from 38% to 65% in seven quarters. The operating cost structure barely moved.","TIKR.com","Est. reading time","9 minutes",1200,630,[195,210,225,240,255],{"id":183,"title":196,"date":197,"excerpt":198,"wordCount":199,"uri":200,"slug":201,"cloudinaryAssetId":202,"featuredImageOriginalUrl":203,"featuredImageMetadata":204,"author":205,"categories":207,"relatedPosts":209},"MercadoLibre Stock Posts Fastest Revenue Growth in Four Years: Should You Buy Now?","2026-06-12 12:00:00","MercadoLibre's credit portfolio nearly doubled to $14.6 billion. The question is whether provision normalization unlocks the margin recovery the valuation needs.",1473,"\u002Fblog\u002Fmercadolibre-stock-posts-fastest-revenue-growth-in-four-years-should-you-buy-now","mercadolibre-stock-posts-fastest-revenue-growth-in-four-years-should-you-buy-now","images\u002FFEATURED-IMAGE-MAKER-837\u002FFEATURED-IMAGE-MAKER-837","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781235406\u002Fimages\u002FFEATURED-IMAGE-MAKER-837\u002FFEATURED-IMAGE-MAKER-837.png?_i=AA",{"altText":196},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":206},[],[208],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":211,"date":212,"excerpt":213,"wordCount":214,"uri":215,"slug":216,"cloudinaryAssetId":217,"featuredImageOriginalUrl":218,"featuredImageMetadata":219,"author":220,"categories":222,"relatedPosts":224},"CoStar Group Stock's Operating Leverage Is Inflecting After 60 Quarters of Revenue Growth and a $33 Price","2026-06-12 11:20:00","CoStar Group stock delivered 60 straight quarters of double-digit revenue growth. The question is whether the cost structure can hold. ",1520,"\u002Fblog\u002Fcostar-group-stocks-operating-leverage-is-inflecting-after-60-quarters-of-revenue-growth-and-a-33-price","costar-group-stocks-operating-leverage-is-inflecting-after-60-quarters-of-revenue-growth-and-a-33-price","images\u002FFEATURED-IMAGE-MAKER-836\u002FFEATURED-IMAGE-MAKER-836","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781234579\u002Fimages\u002FFEATURED-IMAGE-MAKER-836\u002FFEATURED-IMAGE-MAKER-836.png?_i=AA",{"altText":211},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":221},[],[223],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":226,"date":227,"excerpt":228,"wordCount":229,"uri":230,"slug":231,"cloudinaryAssetId":232,"featuredImageOriginalUrl":233,"featuredImageMetadata":234,"author":235,"categories":237,"relatedPosts":239},"Is Domino's Pizza Stock Undervalued in 2026? The Income Statement Suggests the Market Got It Wrong","2026-06-12 10:30:00","Domino's Pizza stock's gross margins hit 29% in Q1 2026, an eight-quarter high, while operating income grew faster than revenue.",1305,"\u002Fblog\u002Fis-dominos-pizza-stock-undervalued-in-2026-the-income-statement-suggests-the-market-got-it-wrong","is-dominos-pizza-stock-undervalued-in-2026-the-income-statement-suggests-the-market-got-it-wrong","images\u002FFEATURED-IMAGE-MAKER-835\u002FFEATURED-IMAGE-MAKER-835","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781233382\u002Fimages\u002FFEATURED-IMAGE-MAKER-835\u002FFEATURED-IMAGE-MAKER-835.png?_i=AA",{"altText":226},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":236},[],[238],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":241,"date":242,"excerpt":243,"wordCount":244,"uri":245,"slug":246,"cloudinaryAssetId":247,"featuredImageOriginalUrl":248,"featuredImageMetadata":249,"author":250,"categories":252,"relatedPosts":254},"Why Cloudflare Stock Looks Undervalued After Its Q1 2026 Developer Platform Results","2026-06-12 10:00:00","Cloudflare stock's fastest revenue growth in six quarters masks a gross margin compression that makes the $701 TIKR target conditional.",1603,"\u002Fblog\u002Fwhy-cloudflare-stock-looks-undervalued-after-its-q1-2026-developer-platform-results","why-cloudflare-stock-looks-undervalued-after-its-q1-2026-developer-platform-results","images\u002FFEATURED-IMAGE-MAKER-834\u002FFEATURED-IMAGE-MAKER-834","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781231486\u002Fimages\u002FFEATURED-IMAGE-MAKER-834\u002FFEATURED-IMAGE-MAKER-834.png?_i=AA",{"altText":241},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":251},[],[253],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],{"id":183,"title":256,"date":257,"excerpt":258,"wordCount":259,"uri":260,"slug":261,"cloudinaryAssetId":262,"featuredImageOriginalUrl":263,"featuredImageMetadata":264,"author":265,"categories":267,"relatedPosts":269},"Norwegian Cruise Line Stock's Cost Recovery Story: What the Margins Say About a $30 Target","2026-06-11 17:00:00","Norwegian Cruise Line Holding's operating margins just rose to 11% while yield guidance fell. Is 2026 the trough the TIKR model is pricing?",1488,"\u002Fblog\u002Fnorwegian-cruise-line-stocks-cost-recovery-story-what-the-margins-say-about-a-30-target","norwegian-cruise-line-stocks-cost-recovery-story-what-the-margins-say-about-a-30-target","images\u002FFEATURED-IMAGE-MAKER-832\u002FFEATURED-IMAGE-MAKER-832","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781165538\u002Fimages\u002FFEATURED-IMAGE-MAKER-832\u002FFEATURED-IMAGE-MAKER-832.png?_i=AA",{"altText":256},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":266},[],[268],{"name":180,"slug":181,"uri":182,"description":171,"postsCount":183},[],[271,291,306,321,335,351,370,385,402,416,431,449],{"id":183,"title":272,"date":273,"excerpt":274,"wordCount":275,"uri":276,"slug":277,"cloudinaryAssetId":278,"featuredImageOriginalUrl":279,"featuredImageMetadata":280,"author":281,"categories":285,"relatedPosts":290},"Lam Research Has Hit All-Time Highs. Here's Why the Cycle May Just Be Getting Started","2026-06-12 12:30:00","Lam Research just broke to all-time highs on a wave of analyst upgrades and record earnings. But the most important signal came from the CFO at the Bank of America Technology Conference, where he described customer demand conversations as the most robust he has seen in his entire career.",1580,"\u002Fblog\u002Flam-research-has-hit-all-time-highs-heres-why-the-cycle-may-just-be-getting-started","lam-research-has-hit-all-time-highs-heres-why-the-cycle-may-just-be-getting-started","images\u002F6-2_1106950b453\u002F6-2_1106950b453","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781234128\u002Fimages\u002F6-2_1106950b453\u002F6-2_1106950b453.png?_i=AA",{"altText":272},{"name":282,"slug":283,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":284},"Wiltone Asuncion","wiltonetikr",[],[286],{"name":287,"slug":288,"uri":289,"description":171,"postsCount":183},"General Investing","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":183,"title":292,"date":293,"excerpt":294,"wordCount":295,"uri":296,"slug":297,"cloudinaryAssetId":298,"featuredImageOriginalUrl":299,"featuredImageMetadata":300,"author":301,"categories":303,"relatedPosts":305},"KLA Corporation Surged 12% Ahead of Its Stock Split. Here's What the Roadmap Means for Investors","2026-06-12 12:20:00","KLA Corporation surged 12.29% on June 11, the session before its 10-for-1 stock split took effect, pushing past its 52-week high. A wave of analyst upgrades followed the BofA Tech Conference, where CFO Bren Higgins signaled the 2026 wafer equipment market could exceed $140 billion and 2027 could be even stronger.",1419,"\u002Fblog\u002Fkla-corporation-surged-12-ahead-of-its-stock-split-heres-what-the-roadmap-means-for-investors","kla-corporation-surged-12-ahead-of-its-stock-split-heres-what-the-roadmap-means-for-investors","images\u002F5-2_110694407ac\u002F5-2_110694407ac","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781234125\u002Fimages\u002F5-2_110694407ac\u002F5-2_110694407ac.png?_i=AA",{"altText":292},{"name":282,"slug":283,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":302},[],[304],{"name":287,"slug":288,"uri":289,"description":171,"postsCount":183},[],{"id":183,"title":307,"date":308,"excerpt":309,"wordCount":310,"uri":311,"slug":312,"cloudinaryAssetId":313,"featuredImageOriginalUrl":314,"featuredImageMetadata":315,"author":316,"categories":318,"relatedPosts":320},"Applied Materials Stock Surged 10% This Week After a $650 Analyst Target. Is the AI Upcycle Already Priced In?","2026-06-12 12:10:00","Applied Materials surged more than 10% on June 11 after Cantor Fitzgerald set a new $650 Street-high price target, citing bookings visibility stretching into 2028. The stock is now up more than 75% year to date and already trading above the TIKR mid-case target to 2030. ",1428,"\u002Fblog\u002Fapplied-materials-stock-surged-10-this-week-after-a-650-analyst-target-is-the-ai-upcycle-already-priced-in","applied-materials-stock-surged-10-this-week-after-a-650-analyst-target-is-the-ai-upcycle-already-priced-in","images\u002F4-3_11069344e9a\u002F4-3_11069344e9a","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781234119\u002Fimages\u002F4-3_11069344e9a\u002F4-3_11069344e9a.png?_i=AA",{"altText":307},{"name":282,"slug":283,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":317},[],[319],{"name":287,"slug":288,"uri":289,"description":171,"postsCount":183},[],{"id":183,"title":322,"date":197,"excerpt":323,"wordCount":324,"uri":325,"slug":326,"cloudinaryAssetId":327,"featuredImageOriginalUrl":328,"featuredImageMetadata":329,"author":330,"categories":332,"relatedPosts":334},"SanDisk Stock Has Surged 40% This Month. Here's What's Driving It Higher"," SanDisk (SNDK) has climbed roughly 40% in the past month, powered by a Morgan Stanley upgrade and fresh AI inference demand spelled out at the Mizuho Technology Conference. ",1388,"\u002Fblog\u002Fsandisk-stock-has-surged-40-this-month-heres-whats-driving-it-higher","sandisk-stock-has-surged-40-this-month-heres-whats-driving-it-higher","images\u002F2-3_110691d2590\u002F2-3_110691d2590","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781234109\u002Fimages\u002F2-3_110691d2590\u002F2-3_110691d2590.png?_i=AA",{"altText":322},{"name":282,"slug":283,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":331},[],[333],{"name":287,"slug":288,"uri":289,"description":171,"postsCount":183},[],{"id":183,"title":336,"date":337,"excerpt":338,"wordCount":339,"uri":340,"slug":341,"cloudinaryAssetId":342,"featuredImageOriginalUrl":343,"featuredImageMetadata":344,"author":346,"categories":348,"relatedPosts":350},"S&P Global Just Answered the AI Question Investors Have Been Asking All Year","2026-06-11 15:30:00","The one question weighing on S&P Global (SPGI) all year finally got a direct answer this week. At the Mizuho Technology Conference on June 10, SVP of Investor Relations Mark Grant revealed specific figures that reframe the AI disruption debate, and made the case that the market's fear is concentrated on a much smaller slice of the business than most investors realize.\n",1745,"\u002Fblog\u002Fsp-global-just-answered-the-ai-question-investors-have-been-asking-all-year","sp-global-just-answered-the-ai-question-investors-have-been-asking-all-year","images\u002F10-1_110630819ab\u002F10-1_110630819ab","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781186590\u002Fimages\u002F10-1_110630819ab\u002F10-1_110630819ab.png?_i=AA",{"altText":345},"S&P Global Just Answered the AI Question Investors Have Been Asking All Year",{"name":282,"slug":283,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":347},[],[349],{"name":287,"slug":288,"uri":289,"description":171,"postsCount":183},[],{"id":183,"title":352,"date":353,"excerpt":354,"wordCount":355,"uri":356,"slug":357,"cloudinaryAssetId":358,"featuredImageOriginalUrl":359,"featuredImageMetadata":360,"author":362,"categories":364,"relatedPosts":369},"Core & Main Stock Beats Q1 Estimates With $1.9B in Revenue as Municipal Demand Holds Firm","2026-06-11 09:15:00"," Core & Main beat Q1 estimates with $1.9B in revenue and adjusted EPS of $0.72, even as residential volumes slid.",1029,"\u002Fblog\u002Fcore-main-stock-beats-q1-estimates-with-1-9b-in-revenue-as-municipal-demand-holds-firm","core-main-stock-beats-q1-estimates-with-1-9b-in-revenue-as-municipal-demand-holds-firm","images\u002FFEATURED-IMAGE-MAKER-824\u002FFEATURED-IMAGE-MAKER-824","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781142940\u002Fimages\u002FFEATURED-IMAGE-MAKER-824\u002FFEATURED-IMAGE-MAKER-824.png?_i=AA",{"altText":361},"Core & Main Stock Beats Q1 Estimates With $1.9B in Revenue as Municipal Demand Holds Firm",{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":363},[],[365],{"name":366,"slug":367,"uri":368,"description":171,"postsCount":183},"Earnings Updates","earnings-updates","\u002Fblog\u002Fcategory\u002Fearnings-updates",[],{"id":183,"title":371,"date":372,"excerpt":373,"wordCount":374,"uri":375,"slug":376,"cloudinaryAssetId":377,"featuredImageOriginalUrl":378,"featuredImageMetadata":379,"author":380,"categories":382,"relatedPosts":384},"Oracle Stock: Q4 2026 Beats Estimates as OCI Revenue Surges 93% Year-Over-Year","2026-06-11 08:59:00","Oracle posted record results on 93% cloud infrastructure growth and a $638 billion RPO, with TIKR pointing to roughly 200% upside by 2030.",1152,"\u002Fblog\u002Foracle-stock-q4-2026-beats-estimates-as-oci-revenue-surges-93-year-over-year","oracle-stock-q4-2026-beats-estimates-as-oci-revenue-surges-93-year-over-year","images\u002FFEATURED-IMAGE-MAKER-823\u002FFEATURED-IMAGE-MAKER-823","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781141728\u002Fimages\u002FFEATURED-IMAGE-MAKER-823\u002FFEATURED-IMAGE-MAKER-823.png?_i=AA",{"altText":371},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":381},[],[383],{"name":366,"slug":367,"uri":368,"description":171,"postsCount":183},[],{"id":183,"title":386,"date":387,"excerpt":388,"wordCount":389,"uri":390,"slug":391,"cloudinaryAssetId":392,"featuredImageOriginalUrl":393,"featuredImageMetadata":394,"author":395,"categories":399,"relatedPosts":401},"Netskope Stock Plunges 25% After Widening Losses and Weak Cash Flow;  Despite Strong Cloud Revenue Growth","2026-06-11 01:21:49","Netskope stock plunged 21% after earnings as widening losses and negative cash flow overshadowed 28% revenue growth. Here's what happened.",668,"\u002Fblog\u002Fnetskope-nasdaq-stock-plunges-twenty-one-percent-after-widening-losses-and-weak-cash-flow-overshadow-strong-cloud-revenue-growth","netskope-nasdaq-stock-plunges-twenty-one-percent-after-widening-losses-and-weak-cash-flow-overshadow-strong-cloud-revenue-growth","images\u002FNTSK-stock_110427cdfe9\u002FNTSK-stock_110427cdfe9","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781093966\u002Fimages\u002FNTSK-stock_110427cdfe9\u002FNTSK-stock_110427cdfe9.png?_i=AA",{"altText":386},{"name":396,"slug":397,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":398},"Aditya Raghunath","adityatikr",[],[400],{"name":366,"slug":367,"uri":368,"description":171,"postsCount":183},[],{"id":183,"title":403,"date":404,"excerpt":405,"wordCount":406,"uri":407,"slug":408,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":409,"featuredImageMetadata":410,"author":411,"categories":413,"relatedPosts":415},"J.M. Smucker Stock Q4: What Drove the 10% Single-Day Surge After Earnings","2026-06-10 13:25:00","J.M. Smucker beat Q4 FY26 estimates on EPS and FCF while Uncrustables crossed $1 billion and free cash flow hit a company record.",1085,"\u002Fblog\u002Fj-m-smucker-stock-q4-what-drove-the-10-single-day-surge-after-earnings","j-m-smucker-stock-q4-what-drove-the-10-single-day-surge-after-earnings","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F06\u002FFEATURED-IMAGE-MAKER-819-600x360.png",{"altText":403},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":412},[],[414],{"name":366,"slug":367,"uri":368,"description":171,"postsCount":183},[],{"id":183,"title":417,"date":418,"excerpt":419,"wordCount":420,"uri":421,"slug":422,"cloudinaryAssetId":423,"featuredImageOriginalUrl":424,"featuredImageMetadata":425,"author":426,"categories":428,"relatedPosts":430},"SailPoint Beats Q1 FY27 on Both Lines as Agentic Pipeline Doubles and ARR Tops $1.16 Billion. What's Next?","2026-06-10 13:05:00","SailPoint beat Q1 FY27 estimates on revenue and EPS as SaaS ARR grew 36% and the Agentic pipeline doubled quarter over quarter.",1041,"\u002Fblog\u002Fsailpoint-beats-q1-fy27-on-both-lines-as-agentic-pipeline-doubles-and-arr-tops-1-16-billion-whats-next","sailpoint-beats-q1-fy27-on-both-lines-as-agentic-pipeline-doubles-and-arr-tops-1-16-billion-whats-next","images\u002FFEATURED-IMAGE-MAKER-818\u002FFEATURED-IMAGE-MAKER-818","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1781095682\u002Fimages\u002FFEATURED-IMAGE-MAKER-818\u002FFEATURED-IMAGE-MAKER-818.png?_i=AA",{"altText":417},{"name":168,"slug":169,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":427},[],[429],{"name":366,"slug":367,"uri":368,"description":171,"postsCount":183},[],{"id":183,"title":432,"date":433,"excerpt":434,"wordCount":435,"uri":436,"slug":437,"cloudinaryAssetId":438,"featuredImageOriginalUrl":439,"featuredImageMetadata":440,"author":441,"categories":443,"relatedPosts":448},"Up 500% in the Past Year, Can Ciena Stock Keep Climbing in 2026?","2026-06-10 12:54:00","Ciena stock is up 508% in a year. With AI driving network demand and a $7.7B backlog, can CIEN hit $745 by 2028? See our valuation model.",1018,"\u002Fblog\u002Fdoubled-in-last-6-months-can-ciena-nyse-stock-keep-climbing-in-2026","doubled-in-last-6-months-can-ciena-nyse-stock-keep-climbing-in-2026","images\u002FCIEN-stock_110404d1d30\u002FCIEN-stock_110404d1d30","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781083130\u002Fimages\u002FCIEN-stock_110404d1d30\u002FCIEN-stock_110404d1d30.png?_i=AA",{"altText":432},{"name":396,"slug":397,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":442},[],[444],{"name":445,"slug":446,"uri":447,"description":171,"postsCount":183},"Valuation","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":183,"title":450,"date":451,"excerpt":452,"wordCount":453,"uri":454,"slug":455,"cloudinaryAssetId":456,"featuredImageOriginalUrl":457,"featuredImageMetadata":458,"author":459,"categories":461,"relatedPosts":463},"Up 25% in the Last 12 Months, Can Ambarella Stock Keep Climbing in 2026?","2026-06-09 12:37:00","Ambarella stock is up 25% in a year. With Edge AI ramping and an $800M Hanwha deal, can AMBA hit $99 by 2029? See our valuation model.",1007,"\u002Fblog\u002Fup-25-in-the-last-12-months-can-ambarella-nasdaq-amba-stock-keep-climbing-in-2026","up-25-in-the-last-12-months-can-ambarella-nasdaq-amba-stock-keep-climbing-in-2026","images\u002FAMBA-stock\u002FAMBA-stock","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1781003990\u002Fimages\u002FAMBA-stock\u002FAMBA-stock.png?_i=AA",{"altText":450},{"name":396,"slug":397,"role":170,"roleTitle":171,"biography":171,"avatar":171,"socialMediaLinks":460},[],[462],{"name":445,"slug":446,"uri":447,"description":171,"postsCount":183},[]]